<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="retraction" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1781979</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2026.1781979</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Retraction: Paeonol suppresses proliferation and motility of non-small-cell lung cancer cells by disrupting STAT3/NF-&#x3ba;B signaling</article-title>
<alt-title alt-title-type="left-running-head">Frontiers Editorial Office</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2026.1781979">10.3389/fphar.2026.1781979</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<collab>Frontiers Editorial Office</collab>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/228891"/>
</contrib>
</contrib-group>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Frontiers Editorial Office, <email xlink:href="mailto:research.integrity@frontiersin.org">research.integrity@frontiersin.org</email>
</corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-01-27">
<day>27</day>
<month>01</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>17</volume>
<elocation-id>1781979</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>01</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Frontiers Editorial Office.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Frontiers Editorial Office</copyright-holder>
<license>
<ali:license_ref start_date="2026-01-27">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<related-article id="RA1" related-article-type="retracted-article" journal-id="Front. Pharmacol." journal-id-type="nlm-ta" xlink:href="10.3389/fphar.2020.572616" ext-link-type="doi">A Retraction of the Original Research Article <article-title>Paeonol suppresses proliferation and motility of non-small-cell lung cancer cells by disrupting STAT3/NF-&#x3ba;B signaling</article-title> by Zhang L, Chen W-X, Li L-L, Cao Y-Z, Geng Y-D, Feng X-J, Wang A-Y, Chen Z-L, Lu Y and Shen A-Z (2020). Front. Pharmacol. 11:572616. doi: <object-id>10.3389/fphar.2020.572616</object-id>
</related-article>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="1"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Pharmacology of Anti-Cancer Drugs</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<p>The journal retracts the 12 November 2020 article cited above.</p>
<p>Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers&#x2019; policies.</p>
<p>This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication has been recorded by the publisher.</p>
<p>Frontiers would like to thank Sholto David for contacting the journal regarding the published article.</p>
</body>
<back>
<fn-group>
<fn fn-type="custom" custom-type="edited-by">
<p>
<bold>Approved by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/20178/overview">Frontiers Editorial Office</ext-link>, Frontiers Media SA, Switzerland</p>
</fn>
</fn-group>
</back>
</article>